What is the Fiscal Year for CalciMedica?
Date: November 14, 2026
CalciMedica's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
California, United States
Industry
Biotechnology
Stock Symbol
CALC
Website
https://www.calcimedica.com/Description
CalciMedica is a clinical-stage biopharmaceutical company developing novel therapies targeting calcium release-activated calcium (CRAC) channels. Our pipeline includes Auxora™, an intravenous CRAC channel inhibitor being developed for acute pancreatitis and pulmonary arterial hypertension, and CM5480, a novel oral CRAC channel inhibitor designed as a potential chronic therapy for pulmonary hypertension and other diseases driven by dysregulated calcium signaling. Our approach is supported by clinical and translational evidence demonstrating the role of CRAC channels in inflammation, vascular remodeling, right ventricular dysfunction and other forms of organ injury. CalciMedica is headquartered in La Jolla, California and trades on Nasdaq under the ticker symbol CALC.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like CalciMedica and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.